Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Carolyn J. Padoa"'
Publikováno v:
Kidney & Blood Pressure Research, Vol 45, Iss 6, Pp 1009-1017 (2020)
Introduction: The C allele of the ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP-1) rs1044498 polymorphism has previously been associated with increased binding of ENPP-1 to the insulin receptor (IR), resulting in decreased IR signalling an
Externí odkaz:
https://doaj.org/article/9e588583f9bd4674897f1c25c8852cda
Publikováno v:
Southern African Journal of HIV Medicine, Vol 21, Iss 1, Pp e1-e15 (2020)
Background: The measurement of serum creatinine is a standard requirement of the medical management of people living with HIV. Renal dysfunction is common, both as a complication of HIV-infection and as a result of its treatment. The detection of abn
Externí odkaz:
https://doaj.org/article/82dd87db9e964421b5c17e8103d1b1e7
Publikováno v:
BMC Endocrine Disorders, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Vitamin D deficiency and the vitamin D pathway have previously been associated with type 1 diabetes (T1D). The majority of vitamin D is transported through the blood bound to the vitamin D binding protein (VDBP). Two polymorphisms
Externí odkaz:
https://doaj.org/article/125692aebbbd402a8bdd477a77f93023
Publikováno v:
BMC endocrine disorders. 22(1)
Background Vitamin D deficiency and the vitamin D pathway have previously been associated with type 1 diabetes (T1D). The majority of vitamin D is transported through the blood bound to the vitamin D binding protein (VDBP). Two polymorphisms in the V
Publikováno v:
BMC Endocrine Disorders
BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-8 (2021)
Background Autoantibodies to β-cell specific antigens are markers of type 1 diabetes. The most recently identified autoantibodies are targeted to the zinc transporter 8 (ZnT8) protein located in the membrane of β-cell insulin secretory granules. Th
Autor:
J. Paul Banga, Laszlo Hegedüs, Jacqueline A. Gilbert, Daniel El Fassi, Carolyn J. Padoa, Claus Henrik Nielsen
Publikováno v:
El Fassi, D, Banga, J P, Gilbert, J A, Padoa, C, Hegedüs, L & Nielsen, C H 2008, ' Treatment of Graves' disease with rituximab specifically reduces the production of thyroid stimulating autoantibodies ', Clinical Immunology, vol. 130, no. 3, pp. 252-258 . https://doi.org/10.1016/j.clim.2008.09.007
Udgivelsesdato: 2008-Oct-27 Treatment of Graves' disease (GD) with the B-lymphocyte depleting agent rituximab in addition to standard methimazole-therapy prolongs remission. Paradoxically, it does not mediate a reduction in thyrotropin receptor antib
Autor:
Nigel J. Crowther, Carolyn J. Padoa
Publikováno v:
Diabetes Research and Clinical Practice. 74:S51-S62
A revolution has occurred in the field of antibody engineering since Kohler and Milstein described a technique for the production of monoclonal antibodies in 1975. Their paper paved the way for future discoveries which have culminated in the use of r
Autor:
E Ortqvist, Mona Landin-Olsson, Carolyn J. Padoa, James W. Thomas, Carina Törn, T. R. Hall, Christiane S. Hampe
Publikováno v:
Clinical and Experimental Immunology. 146:9-14
Summary Autoantibodies to insulin (IAA) are one of the first markers of the autoimmune process leading to type 1 diabetes (T1D). While other autoantibodies in T1D have been studied extensively, relatively little is known about IAA and their binding s
Publikováno v:
Microbial pathogenesis. 80
Thymol and carvacrol from the class of monoterpene phenols are one of the most potent plant essential oil components possessing antimicrobial effects. Known for their wide bioactive spectrum, these positional isomers of isopropyl cresol deplete ergos
Autor:
J. Paul Banga, Jefferson Foote, Carolyn J. Padoa, Christiane S. Hampe, Eva Örtqvist, T. R. Hall, Marinos C. Dalakas, Raghavanpillai Raju
Publikováno v:
The Journal of Immunology. 175:7755-7762
Autoantibodies to the 65-kDa isoform of glutamate decarboxylase GAD65 (GAD65Ab) are strong candidates for a pathological role in Stiff-Person syndrome (SPS). We have analyzed the binding specificity of the GAD65Ab in serum and cerebrospinal fluid (CS